Metacognitive Therapy Compared to Cognitive-behavioral Therapy

This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Generalized Anxiety Disorder Anxiety Disorders Mental Disorders Phobia, Social Phobic Disorders Posttraumatic Stress Disorder (PTSD) Social Anxiety Disorder Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 years or older,
A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
No change in dose during the last six weeks if on pharmacological treatment, and
Ability to read and speak Swedish.

Exclusion criteria

A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
Acute suicide risk, or
Concurrent psychological treatment.

Treatment and study plan

Transdiagnostic metacognitive therapy

Behavioral

Metacognitive therapy focuses on metacognitions.

Disorder-specific cognitive-behavioral therapy

Behavioral

Cognitive-behavioral therapy focuses on cognitions and/or behaviors.

Primary outcomes

Qualitative interview data

Time frame: Up to 13 weeks

Participant responses based on questions posed in an interview

Study contacts

Contact information is provided by the study sponsor or research team.

Benjamin Bohman

CONTACT

[email protected]

0701713443 ext. +46

Nathalie Petersén

CONTACT

[email protected]

0762082221 ext. +46

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Official study title

Transdiagnostic Metacognitive Therapy Compared to Disorder-specific Cognitive-behavioral Therapy for Anxiety Disorders: a Qualitative Study

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Feb 2, 2026
Registry last updated: Feb 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting